Article
CXCL1 and CXCL8: Reliable and feasible biomarkers differentiating intrapulmonary metastasis from multiple primary neoplasms in non-small cell lung cancers.
Cancer biomarkers : section A of Disease markers - 1 Apr 2025
Liu Ao, Sun Tianlin, Qiu Tong, Chen Yunqing, Qi Huiyang, Du Wenxing, Wu Zhe, Huang Zhan, Su Wenqing, Zhu Changbin, Jiao Wenjie
Abstract excerpt
ObjectiveIn NSCLC, the main approach to differentiate between intrapulmonary metastases (IPM) and multiple primary lung cancer (MPLC) is to integrate histopathological and genomic information. Here, we identified viable biomarkers that can distinguish IPM from MPLC by integrating comprehensive genomic profiling (CGP) and targeted RNA sequencing.MethodsWe retrospectively collected tissues from at least two lesions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
